Patent details

EP1984007 Title: USE OF LOW DOSE LOCAL IMMUNE SUPPRESSION TO ENHANCE ONCOLYTIC VIRAL THERAPY

Basic Information

Publication number:
EP1984007
PCT Application Number:
PCT/CA/2007/000187
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP077017754
PCT Publication Number:
WO/2007/093036
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF LOW DOSE LOCAL IMMUNE SUPPRESSION TO ENHANCE ONCOLYTIC VIRAL THERAPY
French Title of Invention:
UTILISATION D'IMMUNOSUPPRESSION LOCALE À FAIBLE DOSE POUR AMÉLIORER UNE THÉRAPIE VIRALE ONCOLYTIQUE
German Title of Invention:
VERWENDUNG VON NIEDRIGDOSIERTEM LOKALER IMMUNSUPPRESSION ZUR VERSTÄRKUNG EINER ONKOLYTISCHEN VIRALEN THERAPIE
SPC Number:

Dates

Filing date:
09/02/2007
Grant date:
19/08/2015
EP Publication Date:
19/08/2015
PCT Publication Date:
23/08/2007
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/10/2008
EP B1 Publication Date:
19/08/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/02/2016
Expiration date:
09/02/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/02/2007
 
 

Name:
Oncolytics Biotech Inc.
Address:
Suite 210 1167 Kensington Crescent N. W., Calgary, AB T2N 1X7, Canada (CA)

Inventor

1

Name:
THOMPSON Bradley, G.
Address:
Canada (CA)

2

Name:
COFFEY Matthew, C.
Address:
Canada (CA)

Priority

1

Priority Number:
773068 P
Priority Date:
13/02/2006
Priority Country:
United States (US)

2

Priority Number:
788898 P
Priority Date:
03/04/2006
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 35/76;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages